Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP
Referred: Emerging Issues(H)
Summary
The bill would prohibit manufacturers and sellers in Missouri from offering intravenous solution containers and tubing that contain DEHP added on purpose. It sets compliance dates of January 1, 2030 for containers and January 1, 2035 for tubing, limits any unintentional DEHP to less than 0.1% by weight, and exempts certain blood‑collection devices. The aim is to lower patient exposure to the chemical.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when HB 3357 changes status, plus AI-powered summaries and stage predictions.
Sign up free